{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:55:58Z","timestamp":1782316558839,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000102","name":"HRSA","doi-asserted-by":"crossref","award":["T32HP19025"],"award-info":[{"award-number":["T32HP19025"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The prevalence of infections caused by extended-spectrum beta-lactamase producing\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                      (ESBL-\n                      <jats:italic>E. coli<\/jats:italic>\n                      ) is increasing worldwide, but the setting in which this increase is occurring is not well defined. We compared trends and risk factors for ESBL-\n                      <jats:italic>E. coli<\/jats:italic>\n                      bacteriuria in community vs healthcare settings.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We collected electronic health record data on all patients with\n                      <jats:italic>E. coli<\/jats:italic>\n                      isolated from urine cultures in a safety-net public healthcare system from January 2014 to March 2020. All analyses were stratified by healthcare-onset\/associated (bacteriuria diagnosed\u2009&gt;\u200948\u00a0h after hospital admission or in an individual hospitalized in the past 90\u00a0days or in a skilled nursing facility resident, N\u2009=\u20091277) or community-onset bacteriuria (bacteriuria diagnosed\u2009&lt;\u200948\u00a0h after hospital admission or in an individual seen in outpatient clinical settings without a hospitalization in the past 90\u00a0days, N\u2009=\u20097751). We estimated marginal trends from logistic regressions to evaluate annual change in prevalence of ESBL-\n                      <jats:italic>E. coli<\/jats:italic>\n                      bacteriuria among all bacteriuria. We evaluated risk factors using logistic regression models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      ESBL-\n                      <jats:italic>E. coli<\/jats:italic>\n                      prevalence increased in both community-onset (0.91% per year, 95% CI 0.56%, 1.26%) and healthcare-onset\/associated (2.31% per year, CI 1.01%, 3.62%) bacteriuria. In multivariate analyses, age\u2009&gt;\u200965 (RR 1.88, CI 1.17, 3.05), male gender (RR 2.12, CI 1.65, 2.73), and Latinx race\/ethnicity (RR 1.52, CI 0.99, 2.33) were associated with community-onset ESBL-\n                      <jats:italic>E. coli<\/jats:italic>\n                      . Only male gender (RR 1.53, CI 1.03, 2.26) was associated with healthcare-onset\/associated ESBL-\n                      <jats:italic>E. coli<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      ESBL-\n                      <jats:italic>E. coli<\/jats:italic>\n                      bacteriuria frequency increased at a faster rate in healthcare-associated settings than in the community between 2014 and 2020. Male gender was associated with ESBL-\n                      <jats:italic>E. coli<\/jats:italic>\n                      bacteriuria in both settings, but additional risks\u2014age\u2009&gt;\u200965 and Latinx race\/ethnicity\u2014were observed only in the community.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13756-021-00983-y","type":"journal-article","created":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T09:03:44Z","timestamp":1628672624000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Trends in prevalence of extended-spectrum beta-lactamase-producing Escherichia coli isolated from patients with community- and healthcare-associated bacteriuria: results from 2014 to 2020 in an urban safety-net healthcare system"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2854-0247","authenticated-orcid":false,"given":"Eva","family":"Raphael","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Maria","family":"Glymour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry F.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,11]]},"reference":[{"key":"983_CR1","unstructured":"Ten threats to global health in 2019. https:\/\/www.who.int\/emergencies\/ten-threats-to-global-health-in-2019."},{"key":"983_CR2","unstructured":"CDC. Antibiotic Resistance Threats in the United States, 2019. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2019."},{"issue":"1","key":"983_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/2047-2994-3-9","volume":"3","author":"SZ Kassakian","year":"2014","unstructured":"Kassakian SZ, Mermel LA. Changing epidemiology of infections due to extended spectrum beta-lactamase producing bacteria. Antimicrob Resist Infect Control. 2014;3(1):9.","journal-title":"Antimicrob Resist Infect Control"},{"key":"983_CR4","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1007\/s10096-019-03655-3","volume":"38","author":"AA van Driel","year":"2019","unstructured":"van Driel AA, Notermans DW, Meima A, Mulder M, Donker GA, Stobberingh EE, Verbon A. Antibiotic resistance of Escherichia coli isolated from uncomplicated UTI in general practice patients over a 10-year period. Eur J Clin Microbiol Infect Dis. 2019;38:2151.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"983_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","volume":"8","author":"JD Pitout","year":"2008","unstructured":"Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8(3):159\u201366.","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"983_CR6","doi-asserted-by":"publisher","first-page":"e770","DOI":"10.1016\/j.ijid.2010.02.2264","volume":"14","author":"PH Bours","year":"2010","unstructured":"Bours PH, Polak R, Hoepelman AI, Delgado E, Jarquin A, Matute AJ. Increasing resistance in community-acquired urinary tract infections in Latin America, five years after the implementation of national therapeutic guidelines. Int J Infect Dis. 2010;14(9):e770-774.","journal-title":"Int J Infect Dis"},{"key":"983_CR7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jgar.2018.03.004","volume":"14","author":"FA Lagunas-Rangel","year":"2018","unstructured":"Lagunas-Rangel FA. Antimicrobial susceptibility profiles of bacteria causing urinary tract infections in Mexico: single-centre experience with 10 years of results. J Glob Antimicrob Resist. 2018;14:90\u20134.","journal-title":"J Glob Antimicrob Resist"},{"issue":"3","key":"983_CR8","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3947\/ic.2017.49.3.184","volume":"49","author":"JJ Park","year":"2017","unstructured":"Park JJ, Seo YB, Lee J. Antimicrobial susceptibilities of Enterobacteriaceae in community-acquired urinary tract infections during a 5-year period: A Single Hospital Study in Korea. Infect Chemother. 2017;49(3):184\u201393.","journal-title":"Infect Chemother"},{"issue":"5","key":"983_CR9","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/cid\/cis942","volume":"56","author":"Y Doi","year":"2013","unstructured":"Doi Y, Park YS, Rivera JI, Adams-Haduch JM, Hingwe A, Sordillo EM, Lewis JS 2nd, Howard WJ, Johnson LE, Polsky B, et al. Community-associated extended-spectrum beta-lactamase-producing Escherichia coli infection in the United States. Clin Infect Dis. 2013;56(5):641\u20138.","journal-title":"Clin Infect Dis"},{"key":"983_CR10","doi-asserted-by":"crossref","unstructured":"de Souza da-Silva AP, de Sousa VS, de Ara\u00fajo Longo LG, Caldera S, Baltazar ICL, Bonelli RR, Santoro-Lopes G, Riley LW, Moreira BM: Prevalence of fluoroquinolone-resistant and broad-spectrum cephalosporin-resistant community-acquired urinary tract infections in Rio de Janeiro: Impact of genotypes ST69 and ST131. Infect Genet Evol. 2020;85:104452.","DOI":"10.1016\/j.meegid.2020.104452"},{"key":"983_CR11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s40471-019-00206-4","volume":"6","author":"CR Butcher","year":"2019","unstructured":"Butcher CR, Rubin J, Mussio K, Riley LW. Risk factors associated with community-acquired urinary tract infections caused by extended-spectrum \u2264-lactamase-producing Escherichia coli: a Systematic review. Curr Epidemiol Rep. 2019;6:300\u20139.","journal-title":"Curr Epidemiol Rep"},{"issue":"7","key":"983_CR12","doi-asserted-by":"publisher","first-page":"e69581","DOI":"10.1371\/journal.pone.0069581","volume":"8","author":"A S\u00f8raas","year":"2013","unstructured":"S\u00f8raas A, Sundsfjord A, Sandven I, Brunborg C, Jenum PA. Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae-a case-control study in a low prevalence country. PLoS ONE. 2013;8(7):e69581.","journal-title":"PLoS ONE"},{"issue":"6","key":"983_CR13","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.tmaid.2016.11.012","volume":"14","author":"JP Strysko","year":"2016","unstructured":"Strysko JP, Mony V, Cleveland J, Siddiqui H, Homel P, Gagliardo C. International travel is a risk factor for extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae acquisition in children: a case-case-control study in an urban U. S. Hospital. Travel Med Infect Dis. 2016;14(6):568\u201371.","journal-title":"Travel Med Infect Dis"},{"issue":"1","key":"983_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1017\/S0950268817002680","volume":"146","author":"UV Ukah","year":"2018","unstructured":"Ukah UV, Glass M, Avery B, Daignault D, Mulvey MR, Reid-Smith RJ, Parmley EJ, Portt A, Boerlin P, Manges AR. Risk factors for acquisition of multidrug-resistant Escherichia coli and development of community-acquired urinary tract infections. Epidemiol Infect. 2018;146(1):46\u201357.","journal-title":"Epidemiol Infect"},{"key":"983_CR15","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1089\/mdr.2020.0058","volume":"27","author":"E Raphael","year":"2020","unstructured":"Raphael E, Chambers HF. Differential trends in extended-spectrum beta-lactamase-producing Escherichia coli infections in four health care facilities in a single metropolitan area: a retrospective analysis. Microb Drug Resist. 2020;27:154.","journal-title":"Microb Drug Resist"},{"key":"983_CR16","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 26th ed. CLSI supplement M100S. Wayne, PA: Clinical and Laboratory Standards Institute; 2016."},{"issue":"3","key":"983_CR17","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1017\/psrm.2017.42","volume":"7","author":"J Esarey","year":"2018","unstructured":"Esarey J, Menger A. Practical and effective approaches to dealing with clustered data. Polit Sci Res Methods. 2018;7(3):541\u201359.","journal-title":"Polit Sci Res Methods"},{"issue":"3","key":"983_CR18","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jped.2016.06.009","volume":"93","author":"YH Kim","year":"2017","unstructured":"Kim YH, Yang EM, Kim CJ. Urinary tract infection caused by community-acquired extended-spectrum \u03b2-lactamase-producing bacteria in infants. Jornal de Pediatria. 2017;93(3):260\u20136.","journal-title":"Jornal de Pediatria"},{"issue":"9","key":"983_CR19","first-page":"538","volume":"19","author":"A Elnasasra","year":"2017","unstructured":"Elnasasra A, Alnsasra H, Smolyakov R, Riesenberg K, Nesher L. Ethnic diversity and increasing resistance patterns of hospitalized community-acquired urinary tract infections in Southern Israel: A Prospective Study. Israel Med Assoc J: IMAJ. 2017;19(9):538\u201342.","journal-title":"Israel Med Assoc J: IMAJ"},{"issue":"9","key":"983_CR20","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1007\/s00467-014-2810-y","volume":"29","author":"O Megged","year":"2014","unstructured":"Megged O. Extended-spectrum \u03b2-lactamase-producing bacteria causing community-acquired urinary tract infections in children. Pediatr Nephrol. 2014;29(9):1583\u20137.","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"983_CR21","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jmii.2013.05.006","volume":"47","author":"N-C Fan","year":"2014","unstructured":"Fan N-C, Chen H-H, Chen C-L, Ou L-S, Lin T-Y, Tsai M-H, Chiu C-H. Rise of community-onset urinary tract infection caused by extended-spectrum \u03b2-lactamase-producing Escherichia coli in children. J Microbiol Immunol Infect. 2014;47(5):399\u2013405.","journal-title":"J Microbiol Immunol Infect"},{"issue":"4","key":"983_CR22","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/jac\/dkl035","volume":"57","author":"E Calbo","year":"2006","unstructured":"Calbo E, Roman\u00ed V, Xercavins M, G\u00f3mez L, Vidal CG, Quintana S, Vila J, Garau J. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum \u03b2-lactamases. J Antimicrob Chemother. 2006;57(4):780\u20133.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"983_CR23","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.diagmicrobio.2016.04.022","volume":"85","author":"SH Lob","year":"2016","unstructured":"Lob SH, Nicolle LE, Hoban DJ, Kazmierczak KM, Badal RE, Sahm DF. Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, SMART 2010\u20132014. Diagn Microbiol Infect Dis. 2016;85(4):459\u201365.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"983_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.annemergmed.2020.08.022","volume":"77","author":"DA Talan","year":"2021","unstructured":"Talan DA, Takhar SS, Krishnadasan A, Mower WR, Pallin DJ, Garg M, Femling J, Rothman RE, Moore JC, Jones AE, et al. Emergence of extended-spectrum \u03b2-lactamase urinary tract infections among hospitalized emergency Department Patients in the United States. Ann Emerg Med. 2021;77(1):32\u201343.","journal-title":"Ann Emerg Med"},{"issue":"2","key":"983_CR25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.acuro.2014.08.001","volume":"39","author":"J Medina-Polo","year":"2015","unstructured":"Medina-Polo J, Guerrero-Ramos F, P\u00e9rez-Cadavid S, Arr\u00e9bola-Pajares A, Sope\u00f1a-Sutil R, Ben\u00edtez-Sala R, Jim\u00e9nez-Alcaide E, Garc\u00eda-Gonz\u00e1lez L, Alonso-Isa M, Lara-Isla A, et al. Community-associated urinary infections requiring hospitalization: risk factors, microbiological characteristics and patterns of antibiotic resistance. Actas Urol Esp. 2015;39(2):104\u201311.","journal-title":"Actas Urol Esp"},{"issue":"5","key":"983_CR26","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2217\/ahe.13.38","volume":"9","author":"TA Rowe","year":"2013","unstructured":"Rowe TA, Juthani-Mehta M. Urinary tract infection in older adults. Aging Health. 2013;9(5):519.","journal-title":"Aging Health"},{"issue":"2","key":"983_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1469-0691.2009.02941.x","volume":"16","author":"\u00d6K Azap","year":"2010","unstructured":"Azap \u00d6K, Arslan H, \u015eerefhano\u011flu K, \u00c7olako\u011flu \u015e, Erdo\u011fan H, Timurkaynak F, Senger SS. Risk factors for extended-spectrum \u03b2-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clin Microbiol Infect. 2010;16(2):147\u201351.","journal-title":"Clin Microbiol Infect"},{"key":"983_CR28","first-page":"7656752","volume":"2018","author":"DS Lee","year":"2018","unstructured":"Lee DS, Lee SJ, Choe HS. Community-acquired urinary tract infection by Escherichia coli in the era of antibiotic resistance. Biomed Res Int. 2018;2018:7656752.","journal-title":"Biomed Res Int"},{"key":"983_CR29","doi-asserted-by":"publisher","unstructured":"Yamaji R, Rubin J, Thys E, Friedman CR, Riley LW. Persistent Pandemic Lineages of Uropathogenic Escherichia coli in a College Community from 1999 to 2017. J Clin Microbiol. 2018;56(4):e01834\u201317. https:\/\/doi.org\/10.1128\/JCM.01834-17.","DOI":"10.1128\/JCM.01834-17"},{"issue":"9","key":"983_CR30","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.1128\/AAC.00528-16","volume":"60","author":"R Zoorob","year":"2016","unstructured":"Zoorob R, Grigoryan L, Nash S, Trautner BW. Nonprescription antimicrobial use in a primary care population in the United States. Antimicrob Agents Chemother. 2016;60(9):5527\u201332.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"983_CR31","doi-asserted-by":"publisher","first-page":"e0198621","DOI":"10.1371\/journal.pone.0198621","volume":"13","author":"A Ponce-de-Leon","year":"2018","unstructured":"Ponce-de-Leon A, Rodriguez-Noriega E, Morfin-Otero R, Cornejo-Juarez DP, Tinoco JC, Martinez-Gamboa A, Gaona-Tapia CJ, Guerrero-Almeida ML, Martin-Onraet A, Vallejo Cervantes JL, et al. Antimicrobial susceptibility of gram-negative bacilli isolated from intra-abdominal and urinary-tract infections in Mexico from 2009 to 2015: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). PLoS ONE. 2018;13(6):e0198621.","journal-title":"PLoS ONE"},{"key":"983_CR32","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1089\/mdr.2020.0128","volume":"27","author":"NJ Tarlton","year":"2020","unstructured":"Tarlton NJ, Petrovic D-F, Frazee BW, Borges CA, Pham EM, Milton AK, Jackson N, deBoer TR, Murthy N, Riley LW. A dual enzyme-based biochemical test rapidly detects third-generation cephalosporin-resistant CTX-M-producing uropathogens in clinical urine samples. Microb Drug Resist. 2020;27:450.","journal-title":"Microb Drug Resist"},{"issue":"9","key":"983_CR33","doi-asserted-by":"publisher","first-page":"635","DOI":"10.14740\/jocmr3928","volume":"11","author":"M Miyazaki","year":"2019","unstructured":"Miyazaki M, Yamada Y, Matsuo K, Komiya Y, Uchiyama M, Nagata N, Takata T, Jimi S, Imakyure O. Change in the antimicrobial resistance profile of extended-spectrum \u03b2-lactamase-producing Escherichia coli. J Clin Med Res. 2019;11(9):635\u201341.","journal-title":"J Clin Med Res"},{"issue":"12","key":"983_CR34","doi-asserted-by":"publisher","first-page":"e0220265","DOI":"10.1371\/journal.pone.0220265","volume":"14","author":"IA Critchley","year":"2019","unstructured":"Critchley IA, Cotroneo N, Pucci MJ, Mendes R. The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017. PLoS ONE. 2019;14(12):e0220265.","journal-title":"PLoS ONE"},{"issue":"6","key":"983_CR35","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S1473-3099(19)30755-8","volume":"20","author":"D van Duin","year":"2020","unstructured":"van Duin D, Arias CA, Komarow L, Chen L, Hanson BM, Weston G, Cober E, Garner OB, Jacob JT, Satlin MJ, et al. Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study. Lancet Infect Dis. 2020;20(6):731\u201341.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"983_CR36","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3109\/00365548.2012.734636","volume":"45","author":"\u00c5 \u00d6stholm Balkhed","year":"2013","unstructured":"\u00d6stholm Balkhed \u00c5, T\u00e4rnberg M, Monstein HJ, H\u00e4llgren A, Hanberger H, Nilsson LE. High frequency of co-resistance in CTX-M-producing Escherichia coli to non-beta-lactam antibiotics, with the exceptions of amikacin, nitrofurantoin, colistin, tigecycline, and fosfomycin, in a county of Sweden. Scand J Infect Dis. 2013;45(4):271\u20138.","journal-title":"Scand J Infect Dis"},{"issue":"2","key":"983_CR37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3109\/23744235.2015.1087648","volume":"48","author":"IN Zykov","year":"2016","unstructured":"Zykov IN, Sundsfjord A, Sm\u00e5brekke L, Samuelsen \u00d8. The antimicrobial activity of mecillinam, nitrofurantoin, temocillin and fosfomycin and comparative analysis of resistance patterns in a nationwide collection of ESBL-producing Escherichia coli in Norway 2010\u20132011. Infect Dis (Lond). 2016;48(2):99\u2013107.","journal-title":"Infect Dis (Lond)"},{"issue":"12","key":"983_CR38","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s11606-015-3395-2","volume":"30","author":"AH Chodos","year":"2015","unstructured":"Chodos AH, Kushel MB, Greysen SR, Guzman D, Kessell ER, Sarkar U, Goldman LE, Critchfield JM, Pierluissi E. Hospitalization-associated disability in adults admitted to a safety-net hospital. J Gen Intern Med. 2015;30(12):1765\u201372.","journal-title":"J Gen Intern Med"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-021-00983-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-021-00983-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-021-00983-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T23:00:50Z","timestamp":1673046050000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-021-00983-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,11]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["983"],"URL":"https:\/\/doi.org\/10.1186\/s13756-021-00983-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-150328\/v1","asserted-by":"object"}]},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,11]]},"assertion":[{"value":"11 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by institutional review boards from UCSF and SFGH (IRB number 19-27233).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"118"}}